Penumbra System RED
Commercial- Indications
- Acute ischemic stroke
Company intelligence / Profile preview
Penumbra’s computer-assisted vacuum thrombectomy (CAVT) technology has demonstrated safety and efficacy in multiple clinical data sets. The CAVT platform improves patient outcomes in clot management across several disease states and reduces healthcare resource utilization. Recent trials have shown positive results for devices like the RED 43 Aspiration Catheter in treating distal medium vessel occlusions in acute ischemic stroke[7][2].
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penumbra.